IL17A and cancer: Both of these subsets can produce IFN-γ upon activation, but the Vδ1+ is reported to produce more IL-17 in some cancers like pancreatic ductal adenocarcinoma and colorectal carcinoma despite limited overall characterization studies (16, 17).